These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 18602127

  • 1. Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis.
    Silveira FT, Lainson R, Gomes CM, Laurenti MD, Corbett CE.
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1075-80. PubMed ID: 18602127
    [Abstract] [Full Text] [Related]

  • 2. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
    Silveira FT, Lainson R, De Castro Gomes CM, Laurenti MD, Corbett CE.
    Parasite Immunol; 2009 Aug; 31(8):423-31. PubMed ID: 19646206
    [Abstract] [Full Text] [Related]

  • 3. American tegumentary leishmaniasis: a quantitative analysis of Langerhans cells presents important differences between L. (L.) amazonensis and Viannia subgenus.
    Xavier MB, Silveira FT, Demachki S, Ferreira MM, do Nascimento JL.
    Acta Trop; 2005 Jul; 95(1):67-73. PubMed ID: 15935321
    [Abstract] [Full Text] [Related]

  • 4. [Immunopathology of American tegumentary leishmaniasis].
    Castés M, Tapia FJ.
    Acta Cient Venez; 1998 Jul; 49(1):42-56. PubMed ID: 10205916
    [Abstract] [Full Text] [Related]

  • 5. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
    Campos MB, Lima LVDR, de Lima ACS, Vasconcelos Dos Santos T, Ramos PKS, Gomes CMC, Silveira FT.
    PLoS One; 2018 Jul; 13(3):e0194383. PubMed ID: 29543867
    [Abstract] [Full Text] [Related]

  • 6. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA, de la Glória Orge Orge M, de Farias Guerra MV, Paes MG, de Oliveira Macêdo V, de Carvalho EM.
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [Abstract] [Full Text] [Related]

  • 7. The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis.
    Moll H.
    Behring Inst Mitt; 1997 Mar; (99):73-8. PubMed ID: 9303204
    [Abstract] [Full Text] [Related]

  • 8. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
    Castro Gomes CM, Sousa MGT, Menezes JPB, Batista MC, Lima ACS, Belda W, Bradshaw D, Gama MEA, Laurenti MD, Silveira FT, Corbett CEP.
    Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
    [Abstract] [Full Text] [Related]

  • 9. Is the in situ inflammatory reaction an important tool to understand the cellular immune response in American tegumentary leishmaniasis?
    Morgado FN, Schubach A, Rosalino CM, Quintella LP, Santos G, Salgueiro M, Conceição-Silva F.
    Br J Dermatol; 2008 Jan; 158(1):50-8. PubMed ID: 17944980
    [Abstract] [Full Text] [Related]

  • 10. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs.
    Ribeiro FC, de O Schubach A, Mouta-Confort E, Schubach TM, de Fátima Madeira M, Marzochi MC.
    Vet Parasitol; 2007 Sep 30; 148(3-4):200-6. PubMed ID: 17689193
    [Abstract] [Full Text] [Related]

  • 11. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR, Filho DC, Argiro L, Dessein H, Prata A, Dessein A, Rodrigues V.
    Hum Immunol; 2009 Jun 30; 70(6):383-90. PubMed ID: 19480861
    [Abstract] [Full Text] [Related]

  • 12. [Role of Langerhans cells in the immunity of leishmaniasis].
    Zuluaga M, Robledo SM.
    Biomedica; 2004 Sep 30; 24(3):302-17. PubMed ID: 15551883
    [Abstract] [Full Text] [Related]

  • 13. Antigenic fractions of Leishmania (Viannia) braziliensis: the immune response characterization of patients at the initial phase of disease.
    Brelaz MC, de Oliveira AP, de Almeida AF, de Assis Souza M, Medeiros ÂC, de Brito ME, Pereira VR.
    Parasite Immunol; 2012 Apr 30; 34(4):236-9. PubMed ID: 22394223
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical features of cutaneous and disseminated cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Paraty, Rio de Janeiro.
    Vieira-Gonçalves R, Pirmez C, Jorge ME, Souza WJ, Oliveira MP, Rutowitsch MS, Da-Cruz AM.
    Int J Dermatol; 2008 Sep 30; 47(9):926-32. PubMed ID: 18937655
    [Abstract] [Full Text] [Related]

  • 16. Golden hamster (Mesocricetus auratus) as an experimental model for Leishmania (Viannia) braziliensis infection.
    Gomes-Silva A, Valverde JG, Ribeiro-Romão RP, Plácido-Pereira RM, Da-Cruz AM.
    Parasitology; 2013 May 30; 140(6):771-9. PubMed ID: 23369503
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alterations in phenotypic profiles of peripheral blood cells from patients with human American cutaneous leishmaniasis following treatment with an antimonial drug and a vaccine.
    Botelho AC, Mayrink W, Oliveira RC.
    Acta Trop; 2009 Nov 30; 112(2):143-8. PubMed ID: 19631187
    [Abstract] [Full Text] [Related]

  • 20. American cutaneous leishmaniasis in horses from endemic areas in the north-central mesoregion of Paraná state, Brazil.
    Vedovello Filho D, Jorge FA, Lonardoni MV, Teodoro U, Silveira TG.
    Zoonoses Public Health; 2008 Apr 30; 55(3):149-55. PubMed ID: 18331518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.